- Home
- APDN vs SONN Comparison
APDN vs SONN Comparison
Compare APDN & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APDN
- SONN
- Stock Information
- Founded
- APDN 1983
- SONN N/A
- Country
- APDN United States
- SONN United States
- Employees
- APDN N/A
- SONN N/A
- Industry
- APDN Other Consumer Services
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- APDN Consumer Discretionary
- SONN Health Care
- Exchange
- APDN Nasdaq
- SONN Nasdaq
- Market Cap
- APDN 4.2M
- SONN 3.8M
- IPO Year
- APDN N/A
- SONN N/A
- Fundamental
- Price
- APDN $5.37
- SONN $1.25
- Analyst Decision
- APDN Strong Buy
- SONN Strong Buy
- Analyst Count
- APDN 1
- SONN 1
- Target Price
- APDN $1,125.00
- SONN $20.00
- AVG Volume (30 Days)
- APDN 129.8K
- SONN 39.8K
- Earning Date
- APDN 05-15-2025
- SONN 05-13-2025
- Dividend Yield
- APDN N/A
- SONN N/A
- EPS Growth
- APDN N/A
- SONN N/A
- EPS
- APDN N/A
- SONN N/A
- Revenue
- APDN $3,790,616.00
- SONN $1,000,000.00
- Revenue This Year
- APDN $57.08
- SONN $5,376.22
- Revenue Next Year
- APDN $40.00
- SONN N/A
- P/E Ratio
- APDN N/A
- SONN N/A
- Revenue Growth
- APDN N/A
- SONN 978.39
- 52 Week Low
- APDN $4.37
- SONN $1.08
- 52 Week High
- APDN $2,655.00
- SONN $16.00
- Technical
- Relative Strength Index (RSI)
- APDN 22.45
- SONN 51.70
- Support Level
- APDN $4.96
- SONN $1.13
- Resistance Level
- APDN $6.50
- SONN $1.21
- Average True Range (ATR)
- APDN 1.06
- SONN 0.08
- MACD
- APDN 0.39
- SONN 0.00
- Stochastic Oscillator
- APDN 17.44
- SONN 56.67
About APDN Applied DNA Sciences Inc.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.